Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC30009223;9224;9225 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563
N2AB30009223;9224;9225 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563
N2A30009223;9224;9225 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563
N2B29549085;9086;9087 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563
Novex-129549085;9086;9087 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563
Novex-229549085;9086;9087 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563
Novex-330009223;9224;9225 chr2:178768838;178768837;178768836chr2:179633565;179633564;179633563

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-20
  • Domain position: 32
  • Structural Position: 47
  • Q(SASA): 0.2818
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/R None None 0.999 N 0.593 0.416 0.314417295294 gnomAD-4.0.0 1.59063E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85651E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.8031 likely_pathogenic 0.8194 pathogenic -0.881 Destabilizing 0.999 D 0.684 prob.neutral None None None None N
K/C 0.8861 likely_pathogenic 0.9022 pathogenic -0.951 Destabilizing 1.0 D 0.813 deleterious None None None None N
K/D 0.957 likely_pathogenic 0.9586 pathogenic -0.725 Destabilizing 1.0 D 0.795 deleterious None None None None N
K/E 0.5895 likely_pathogenic 0.596 pathogenic -0.498 Destabilizing 0.999 D 0.613 neutral N 0.506124759 None None N
K/F 0.9711 likely_pathogenic 0.9747 pathogenic -0.258 Destabilizing 1.0 D 0.833 deleterious None None None None N
K/G 0.9195 likely_pathogenic 0.9229 pathogenic -1.318 Destabilizing 1.0 D 0.746 deleterious None None None None N
K/H 0.5314 ambiguous 0.5538 ambiguous -1.202 Destabilizing 1.0 D 0.756 deleterious None None None None N
K/I 0.712 likely_pathogenic 0.7403 pathogenic 0.314 Stabilizing 1.0 D 0.845 deleterious D 0.552277136 None None N
K/L 0.733 likely_pathogenic 0.7443 pathogenic 0.314 Stabilizing 1.0 D 0.746 deleterious None None None None N
K/M 0.5804 likely_pathogenic 0.614 pathogenic -0.095 Destabilizing 1.0 D 0.754 deleterious None None None None N
K/N 0.831 likely_pathogenic 0.8445 pathogenic -1.096 Destabilizing 1.0 D 0.757 deleterious D 0.591784175 None None N
K/P 0.9956 likely_pathogenic 0.9951 pathogenic -0.058 Destabilizing 1.0 D 0.788 deleterious None None None None N
K/Q 0.2464 likely_benign 0.2541 benign -0.905 Destabilizing 1.0 D 0.757 deleterious N 0.505432155 None None N
K/R 0.1081 likely_benign 0.1091 benign -0.526 Destabilizing 0.999 D 0.593 neutral N 0.500266614 None None N
K/S 0.7921 likely_pathogenic 0.8067 pathogenic -1.698 Destabilizing 0.999 D 0.65 neutral None None None None N
K/T 0.4039 ambiguous 0.4234 ambiguous -1.231 Destabilizing 1.0 D 0.776 deleterious N 0.506989142 None None N
K/V 0.6641 likely_pathogenic 0.6877 pathogenic -0.058 Destabilizing 1.0 D 0.769 deleterious None None None None N
K/W 0.9646 likely_pathogenic 0.969 pathogenic -0.224 Destabilizing 1.0 D 0.811 deleterious None None None None N
K/Y 0.9138 likely_pathogenic 0.9261 pathogenic 0.091 Stabilizing 1.0 D 0.799 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.